310 Drugs and Their Actions. 2 cr. Introduces students to the biological effects of drugs on human health. Emphasis on how drugs, especially those used in diseases of major human health significance, act in the body. Drugs that are abused also will be covered. This course is not intended for medical, nursing, pharmacy, and physician assistant students. P: HS or coll chem & biol, or cons inst. Not open for cr to Nursing, Phys Asst, & School of Pharm stdts.
401 Survey of Pharmacology. 3 cr. Pharmacological and toxicological actions and therapeutic use of important drugs. P: Physiol 335; Biochem 201 or 501 or Bmolchem 314. Not open for credit to School of Pharm stdts.
420 Introduction to Drug Action and Drug Delivery I. 4 cr. Applications of physical principles and modern methods of analysis to pharmaceutical systems. P: DPM-1 or Tox-3 st; Chem 103-104 & 343, 344, 345, Math 221, & Physics 103-104.
421 Introduction to Drug Action and Drug Delivery II. 4 cr. A conceptual introduction to the way that drugs act and are processed in vivo, including receptor theory, ligand-macromolecule binding, biopharmaceutics, drug metabolism, pharmacokinetics, and pharmacodynamics. P: DPM-1 or Tox-3 st; Phm Sci 420, Physiol 335.
430 Biological Interactions with Materials. (Crosslisted with BME) 3 cr. This course addresses the range of materials currently being utilized for various biomedical applications, the biological systems governing biomaterial applications, analytical techniques pertinent to biomaterial evaluation, and selected major medical applications in which biomaterials play an important role. P: 1 yr of general biol or two semesters of zool, & 1 semester of organic chem, or cons inst.
432 Pharmaceutical Biochemistry. 4 cr. Chemistry of metabolic processes and products of living matter with emphasis on pharmaceutical and medicinal aspects as well as recombinant DNA technology. Laboratory experience with the chemistry of metabolic processes, products of living matter and recombinant DNA. P: DPH-1 or Tox-3 st.
490 Selected Topics in Pharmaceutical Sciences. 1-4 cr. P: Graded on a lettered basis; requires cons inst.
491 Selected Topics in Pharmaceutical Sciences. 1-4 cr. P: cons inst.
521 Pharmacology I. 3 cr. Pharmacological actions of important drugs, including drugs that affect the peripheral nervous system, the central nervous system, and the gastrointestinal tract. P: DPM-2 or Tox-4 st; Bact 303, Physiol 335, Phm Sci 432, Path 404.
522 Pharmacology II. 3 cr. Pharmacological actions of important drugs, including hematopoietic, thrombolytic, antihyperlipidemic, immunopharmacologic, anticancer, anti-inflammatory, diuretic, antihypertensive, antianginal, and anti-arrhythmic agents, and agents used to treat congestive heart failure. P: Phm Sci 521.
531 Medicinal Chemistry I. 2 cr. Chemistry of medicinal products, including cholinergic, adrenergic, dopaminergic and serotonergic agents, antidepressants, sedative/hypnotics, antianxiety drugs, opioid drugs acting at histamine receptors, and inhibitors of mediator release. P: Phm Sci 432.
532 Medicinal Chemistry II. 2 cr. Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors. P: Phm Sci 531.
540 Drug Delivery Systems. 4 cr. The application of physical, chemical and biological principles to the study of drug delivery using a variety of solid, solution and disperse systems as dosage forms. Rationale for therapeutic use, formulation and manufacture, and evaluation of stability and bioavailability. P: Phm Sci 420, 421; con reg in Phm Sci 541.
541 Drug Delivery Systems Laboratory I. 3 cr. Introductory laboratory course in compounding and dispensing of pharmaceutical dosage forms, including sterile products. Includes practice in interpretation of prescription orders, pharmaceutical calculations, compounding procedures, physical manipulation of drugs and dosage form components, and product packaging and labeling. P: Phm Sci 420, 421; con reg in Phm Sci 540.
542 Drug Delivery Systems Laboratory II. 3 cr. Advanced extemporaneous prescription compounding and preparation of sterile products, with emphasis on physico-chemical stability and compatibility of drugs and dosage forms. Also addresses principles of appraisal, comparison, and selection of appropriate commercial brand name and generic products. P: Phm Sci 540, 541, Stat 541; con reg in Phm Prac 570, S&A Phm 511.
558 Laboratory Techniques in Pharmacology and Toxicology. 2 cr. Basic laboratory techniques employed in pharmacological and toxicological research. P: Jr st in the B.S. Pharmacology & Toxicology program.
623 Pharmacology III. 2 cr. Pharmacological actions of important drugs, including antimicrobial and antiviral drugs, hormones and other drugs affecting the endocrine system. P: For DPM stdts, Phm Sci 522; for TOX stdts, con reg in Phm Sci 521.
625 Toxicology I. (Crosslisted with M&Envtox, Medicine, Oncology, Path, Phmcol M, Pop Hlth, Ahabs) 3 cr. Basic principles of toxicology and biochemical mechanisms of toxicity in mammalian species and man. Correlation between morphological and functional changes caused by toxicants in different organs of the body. P: Biochem 501 & Physiol 335 or cons inst. Path 401 & Phmcol 401 or equiv recommended.
626 Toxicology II. (Crosslisted with M&Envtox, Medicine, Path, Phmcol M, Pop Hlth, Ahabs) 3 cr. A course surveying the basic methods and fundamental biochemical mechanisms of toxicity. Toxicity in mammalian organ systems, techniques for evaluating toxicity, as well as mechanisms of species specificity, and environmental interactions (with toxicant examples) are presented. P: Env Tox 625 or cons inst.
635 Drug Interactions. 1-2 cr. This course will develop the student's ability to use physiological, pharmacological, physical-chemical, pharmacokinetic, and pharmacodynamic concepts to analyze and assess drug-drug interactions. P: Ph-3 or DPM-1 st, or cons inst.
638 Nonprescription Medications. 2-3 cr. The lecture provides students with the knowledge needed to perform triage and make therapeutic recommendations for illnesses commonly encountered in ambulatory pharmacy practice. The lab expands upon lecture knowledge, provides active learning strategies for teaching triage skills, and provides opportunities to practice the application of triage skills. P: Phm Prac 555-556 & Phm Sci 521-522.
640 Substance Abuse and Chemical Dependence. 2 cr. This course addresses the pharmacology and toxicology of abused and dependence-producing substances, as well as treatment approaches for alcoholism, nicotine dependence, opioid dependence, and cocaine dependence. P: Phm Sci 401 or 471, 472, 473, 474 or equiv, or cons inst.
645 Pharmaceutical Biotechnology and Pharmaco-genomics. 2-3 cr. Facilitates the understanding and application of the principles of pharmaceutical biotechnology and pharmacogenomics. The third, optional, elective credit, open only to Pharm.D. students, will consist of clinical case studies in biotechnology and pharmacogenomics, to apply theory to clinical pharmacy practice. P: Phm Sci 432 & DPH-3 st, or cons inst; 2 cr required, with 3rd cr open only to Pharm.D. stdts as a prof elective.
677 Natural Product Chemistry and Engineered Biosynthesis. 3-4 cr. For undergraduate seniors and graduate students interested in the biosynthesis of natural products and genetic engineering of second metabolism for drug discovery and development. Covers these natural products classes: fatty acids, polyketides, carbohydrates, terpenoids, metabolites of shikimate origin, peptides and B-lactams, and alkaloids. P: Biochem 507-508, or Chem 547 or 641, or cons inst.
699 Advanced Independent Study. 0-3 cr. P: cons inst.
731 Selected Topics in Natural Product Chemistry. 2 cr. Important recent developments in the chemistry of pharmacologically active natural products. P: Chem 641 or cons inst.
732 Selected Topics in Medicinal Chemistry. 2 cr. Types of synthetic compounds of medicinal value presently under development. P: Grad st.
766 Molecular Recognition. (Crosslisted with Chem) 2-3 cr. Origin, nature, classification, and description of intermolecular forces. The hydrophobic effect. Molecular complexes, binding constants, and their measurements. General principles of self-assembly, molecular recognition, complex formation, host design. Supramolecular systems and their dynamics. Micelles, bilayers, vesicles, biological membranes. P: Chem 561 or equiv physical chem or cons inst.
767 Solution Kinetics in Pharmaceutical Systems. 2 cr. Theoretical and experimental basis of kinetic studies of reactions in solution, with applications to pharmaceutically important problems. P: Chem 561.
768 Pharmacokinetics. 2 cr. Quantitative aspects of drug absorption, distribution, metabolism, and excretion. Philosophy and applications of pharmacokinetic modeling and its use in clinical practice. P: cons inst.
770 Special Topics in Pharmaceutical Sciences. 1-3 cr. Current status of the theoretical aspects of pharmaceutical biochemistry and their practical application. P: cons inst.
773 Solids and Powder Technology. 2 cr. Theory basic to the technology of solid dosage forms used in pharmacy and medicine. P: Phm Sci 458, 459.
774 Interfacial and Colloidal Phenomena. 3 cr. Introduction to selected topics in interfacial and colloidal science. Topics include: surface thermodynamics; monolayers; adsorption; wetting; micellization; particle interactions; steric and electrical stabilization; sedimentation. P: Chem 561.
780 Special Topics in Pharmaceutical Sciences. 1-3 cr. P: cons inst.
890 Highlights at the Chemistry-Biology Interface I. 1 cr. Principles of key discoveries at the chemistry-biology interface. This course is required of all Chemistry-Biology Interface trainees. P: Grad st; cons of program director.
891 Highlights at the Chemistry-Biology Interface II. 1 cr. Principles of key discoveries at the chemistry-biology interface. This course is required of all Chemistry-Biology Interface trainees. P: Grad st; cons of program director.
910 Special Topics at the Chemistry-Biology Interface I. 1 cr. Special topics at the chemistry-biology interface. This course is required of all Chemistry-Biology Interface trainees. P: Grad st; cons of program director.
911 Special Topics at the Chemistry-Biology Interface II. 1 cr. Special topics at the chemistry-biology interface. This course is required of all Chemistry-Biology Interface trainees. P: Grad st; cons of program director.
931 Conference of Research Workers. 1 cr. P: Grad st.
932 Conference of Research Workers. 1 cr. Continuation of 931. P: Grad st.
990 Research. 1-12 cr. P: Grad st.
999 Advanced Independent Study. 1-12 cr. P: Grad st & cons inst.
470 Computer Applications in Pharmacy Practice. 3 cr. Develops skills applicable to community and hospital pharmacy practice settings. Emphasis on database and computer applications unique to pharmacy practice. No prior computer experience or knowledge is necessary. P: Enrollment in School of Pharmacy.
490 Selected Topics in Pharmacy Practice. 1-4 cr. P: Ph-2 st & cons inst.
570 Drug Literature Evaluation. 2 cr. Fundamentals of literature evaluation to enable students to make decisions regarding the clinical use of drugs. P: For entry-level Pharm D. stdts, DPM-2 st, Phm Prac 555, & con reg in Phm Prac 556. For all other stdts, cons inst.
600 Interdisciplinary Rural Primary Health Care Practice. (Crosslisted with Nursing, Phy Asst, Soc Work) 2 cr. Using a framework of interdisciplinary health care teams and community-based practice models, the course focuses on the provision of primary health care services in rural and underserved populations. P: Sr st in a health professions prgm e.g. nurs, phy asst, pharm, soc wrk, med, nutr, occ ther, phy ther or cons inst.
605 Pharmacotherapeutics for Advanced Practice Nurses. (Crosslisted with Nursing) 3 cr. Pharmacotherapeutics content and application for advanced practice nursing. Emphasis on selection of appropriate therapeutics, development of clinical decision-making skills, and examination of legal, ethical, and safety issues in prescribing medications. P: An undergrad pharmacology crse.
608 Safety and Quality in the Medicatgion Use System. 3 cr. Addresses the problems of medication errors and quality in health care, problem resolutions, methods of assessment, and intervention implementation and quality management. P: DPH-3 st or cons inst.
650 Comprehensive Immunization Delivery. 1 cr. Addresses vaccine-preventable diseases and the implementation of pharmacy-based immunization delivery programs. P: Phm Prac 655 or cons inst.
672 Herbals, Homeopathy, and Dietary Supplements. (Crosslisted with Nutr Sci) 2-3 cr. Covers regulations and clinical science regarding the use of herbals, homeopathic remedies, and dietary supplements, focusing on peer-reviewed studies and integration with allopathic drugs; includes discussion of marketing issues. P: Phm Sci 432 or Biochem 501 or Bmolchem 314; Physiol 335; or cons inst.
699 Advanced Independent Study. 0-3 cr. P: cons inst.
746 Interdisciplinary, Coordinated Care of the Child with Chronic Illness. (Crosslisted with Pediat, Nursing, Soc Work) 2-3 cr. Workshops, case conferences/simulations, and problem-solving exercises are presented by members of an interdisciplinary pediatric team and guest speakers. Course integrates knowledge from medicine, nursing, pharmacy, social work, nutrition, respiratory care, home care, and education with an emphasis on critical transition points in the care of children with chronic disease. P: Grad st and/or cons inst.
961 Conference of Research Workers Hospital Pharmacy. 1 cr. P: Grad st.
962 Conference of Research Workers Hospital Pharmacy. 1 cr. P: Grad st.
999 Advanced Independent Study. 1-12 cr. P: DPM-1 st & cons inst.
401 History of Pharmacy. (Crosslisted with Hist Sci) 2 cr. Pharmaceutical field, from antiquity to modern medical care; professional; structuring in principal countries of the West. P: Jr st or cons inst.
411 Psychosocial and Management Aspects of Pharmacy. 3 cr. Introduction to the patient's perspective of health, illness, and patient-provider interactions, including educational assessment and consultation related to medication use. Management concepts are applied to strategies and approaches for improved patient care processes and systems, focusing on enhanced patient outcomes. P: Soc 210 or 211, or Anthro 100 or 104, & Psych 202 or 530.
414 Pharmacy in the Health Care System. 3 cr. Introduction to the health care system and pharmacy within it. Fundamentals of finance, economics, and pharmacoeconomic decision analysis in pharmacy practice. Marketing and the behavior of firms and consumers in pharmacy markets. P: DPH-1 st, S&A Phm 411.
490 Selected Topics in Social and Administrative Pharmacy. 1-4 cr. P: Graded on a lettered basis; requires cons inst.
511 Pharmacy Law and Regulation. 2-3 cr. Federal and Wisconsin laws related to drug manufacture, drug distribution, drug use, and pharmacy practice. P: DPM-2 st; S&A Phm 411, 414, 510.
561 Greek and Roman Medicine and Pharmacy. (Crosslisted with Classics, History, Med Hist, Hist Sci) 3 cr. Greek and Roman medicine and drug lore from the Pre-Socratics to Oribasius (c. 600 B.C.-A.D. 350), including the backgrounds of ancient Egyptian and Mesopotamian medicine. P: Jr or Sr st, or cons inst.
562 Byzantine Medicine and Pharmacy. (Crosslisted with History, Med Hist, Hist Sci, Medieval) 3 cr. Byzantine and Islamic medicine and drug lore from Oribasius to the beginnings of the Italian Renaissance (c. 350-c. 1400 A.D.). P: Jr or Sr st or cons inst.
618 Professional Decision-Making in Pharmacy Practice. 2-3 cr. Application of ethical theory to problems in pharmacy practice. Emphasis on contemporary patient care situations and evolving issues related to drug technology, drug use, and patient-pharmacist relations. P: DPH-3 st, S&A Phm 511, & Phm Prac 556; 2 cr required, 3rd cr avail as a professional elective.
622 Proseminar in Social and Administrative Pharmacy. 1-3 cr. Problems in pharmaceutical sociology, psychology, management, finance and economics, including: drug prescribing/use, distribution, and payment; patient care and pharmaceutical service delivery; pharmaceutical industry; and pharmaceutical policy and regulation . May be repeated. P: DPH-1 or Jr st.
630 Pharmacy Finance and Reimbursement. 3 cr. Analysis and evaluation of financial operations in community pharmacy practice, including third-party reimbursement systems and other factors influencing financial operations. P: S&A Phm 411 & 412.
652 Pharmacist Communication: Educational and Behavioral Interventions. 2 cr. Intermediate principles of pharmacist communication with patients and other care givers; weekly communications laboratory provides opportunity to refine skills in listening, interviewing, counseling, and use of various educational and behavioral strategies to improve drug use. P: DPM-3 st & S&A Phm 411.
699 Advanced Independent Study. 0-3 cr. P: cons inst.
711 Evaluation of Pharmaceutical Services, Programs, and Policies. 3 cr. Development of skills in the methods, techniques, and problems encountered in conducting evaluations of pharmaceutical services, programs, and policies. P: Grad st or cons inst.
712 Problems in Drug Marketing. 2 cr. Decision-making process applied to drug marketing problems at each level of the channel of distribution; examples progress from isolated marketing problems to the integrated marketing complex. P: Grad st and S&A Phm 711.
713 Pharmaceuticl Marketing and Policy. 3 cr. Marketing and policy aspects of prescription drugs from the perspective of the pharmaceutical industry; overview of the industry, the marketing mix, policies and regulations related to pharmaceuticals. P: Grad st or cons inst.
714 Social Organization of Pharmacy. 3 cr. Examination of theories, methodologies, and research related to social organization of the profession and practice of pharmacy, the pharmaceutical industry, pharmaceutical regulation, and national/international pharmacy sectors. P: Grad st or cons inst.
715 Social Behavioral Theories in Pharmacy, Drug Use, and Health Behavior. 3 cr. Critical review and application of social behavioral theories, methodologies, and research to current problems in pharmacy, pharmacist communication and interaction with consumers and other poviders, use of prescription and nonprescription drugs, and self-care. P: Grad st or cons inst.
716 Advanced Hospital Pharmacy Administration. 2 cr. For second-year hospital pharmacy students. Various components necessary to become an accomplished administrator of a pharmacy department in a hospital or organized health care setting. P: S&A Phm 616, minimum of one yr in MS-Residency Program, or cons inst.
911 Conference of Research Workers. 1 cr. P: Grad st.
912 Conference of Research Workers. 1 cr. P: Grad st.
921 Seminar—Research in the Sociology of Medicine. (Crosslisted with Soc, Rur Soc) 3 cr. Research in social organization of the hospital, and treatment and control of illness. P: Grad st & cons inst.
990 Research. 1-12 cr. P: Grad st.
999 Advanced Independent Study. 1-12 cr.